1 Regulation of drug research. 2 What is drug research? There are two approaches: a wider and a pragmatic one The latter make a difference between „research.

Slides:



Advertisements
Similar presentations
Material Safety Data Sheets (MSDS)
Advertisements

1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI.
OMNI FACILITY SERVICES Copyright  Progressive Business Publications Material Safety Data Sheets.
The GSBL-Data Pool Common Data Pool for Chemicals BEF Workshop - Riga / / 1Jahnke / Menger [German Federal Environmental Agency]
Stefan Franzén Introduction to clinical trials.
Reference, Retention and Reserve Samples
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
SÄTEILYTURVAKESKUS STRÅLSÄKERHETSCENTRALEN RADIATION AND NUCLEAR SAFETY AUTHORITY Protection of the environment from ionising radiation - views of a regulator.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Towards a global plan to fight against bioterrorism in synergy with Russian Federation Novosibirsk
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
Good Laboratory Practices (GLPs)
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Pharmacologist & Toxicologist CTE Introduction. What is a Pharmacologist? Develop new drugs to cure, treat, and prevent disease. Develop new drugs to.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
INTRODUCTION TO RA.
What is the GLP?.
Environmental Review of the Use of Pesticides in USAID Projects: Rationale & Approaches.
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
Exploratory IND Studies
SFDA-2007 الهيئة العامة للغذاء والدواء Bioequivalence Studies of Generic Pharmaceutical Products Workshop-Day II Introduction and workshop Objectives By:
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Important informations
TECHNICAL REQUIREMENTS FOR MINOR APPLICATIONS E MOKANTLA 3 SEPTEMBER 2013.
SCP / Sps / REACH Objective : Safe use of chemicals.
Marcel H.N. Hoefnagel 2 November 2007 BIOSIMILARS are not Generics But similar.
1 Legislation and Institutional/Administrative Capacities - PLANT PROTECTION - - PLANT PROTECTION - Sub-Committee for Agriculture and Fishery European.
QSR and GLP What exactly are these?.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Material Safety Data Sheet
Role of VICH and VICH guidelines in the approval process for veterinary medicinal products David Mackay, European Medicines Agency VICH Workshop – Dar.
Application of VICH GLs – extract from group discussion General: VICH GLs do not prescribe the data package to be submitted for registration, they merely.
GLP/GCP: Requirement and implementation (Japan) Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan 1 5 th VICH Outreach.
Introduce GLP/GCP into China Shixin XU, PhD, Prof. China IVDC.
DMF Procedures and Communication between API, FFP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Biotechnology and the Workplace. Roles for Biomedical scientists Laboratory technicians: - Healthcare or clinical labs (CLS, MLT) - Research laboratories.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
Tanzania, August 2006 Dr. Barbara Sterzik, BfArM, Bonn 1 Bioequivalence dossier requirements for the prequalification project WHO Training Workshop.
Regulation for Aquaculture Medicine Dr. Sasi Jaroenpioj Department of Livestock Medicine THAILAND 8 July 2015.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Registration requirements for vaccines -Strategies to implement VICH GLs- Takashi KOZASA, DVM National Veterinary Assay Laboratory, Ministry of Agriculture,
נמטוציטים משושנת ים Eli. S Lec. No.2.
Requirements for GLP and GCP in the EU
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
Presentation on Good Manufacturing Practice
The Lifecycle of Pharmaceutical products
The role of the HPRA in the authorisation of veterinary medicinal products The role of the Health Products Regulatory Authority in the authorisation of.
Waiving Target Animal Batch Safety Testing for vaccines
OECD Principles of GLP and Test Guidelines
From Lab to Label: Innovations That Feed The World
Abscission Registration Budget and Timeline
Proportion of total R&D expenditure by function in 2005
International Initiatives and the U.S. HPV Challenge Program
Quality guidelines on impurities
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Pyatigorskaya Nataliya Valeryevna
Presentation transcript:

1 Regulation of drug research

2 What is drug research? There are two approaches: a wider and a pragmatic one The latter make a difference between „research of drugs” and „research of biologically active substances” Before we start…

3 Research of drugs marketed drug product as soon as possible are taken into account, building the research on them what is necessary for registration Research of biologically substances publication, dissertation… Are not taken into account, only the rules of the „Art of academic research” What is interesting aim the drug registration/authorisation rules subject

4 Consecutive phases of real drug research „molecule research” Fixing the quality of the API animal toxicology animal pharmacology dosage-form development Fixing the API manuf. technology Fixing the dosage-form manuf. technology human clinical trials registration (authorisation) Time scale (start) API = active pharmaceutical ingredient

5 Can drug research be regulated at all? Its some fields by laws, directly – animal experiments: general principles and quality assurance of some studies – human clinical trials Other fields by laws only indirectly a piece of law specifies how the documentation should be compiled (e.g. listing chapters and types of experiments) and submitted for registration, but directly only by „soft law” (=guidelines)

6 Research for a new drug: New API found synthesis manufacture physical and chemical quality Decomposition routes Animal experiments pharmacology toxicology Drug product development Composition (its logics) manufacture chem. and dosage-form control stability Clinical trials on humans direct regul. Dossier structure, information sheets, authorisation direct regul. „chemical dossier” indirect regul. direct regul. (GMP) „non-cinical dossier” indirect regul. direct regul. (GLP) „chem.-pharmaceutical dossier” direct regul. (GMP) indirect regul.

Regulation of chemical- pharmaceutical research Indirect regulation will be discussed in connection with the topic „registration, authorisation” The same for dossier structure Direct regulation: GMP: when we discuss „manufacture” 7

Regulation of animal experiments 8

9 In many countries: Animal Protection Act Definition of „animal experiment” and „torture of animals” Killing an animal: if absolutely necessary, but in narcosis Torture of animals is forbidden Some countries: except – excirbation of goos feather (for bed-clothes) – crumming of gees or ducks (for goos liver)

10 Regulation of animal experiments, 2 Before starting, you should check whether it is regulated in your country ! If regulated, is the „experimental animal” defined? (E.g.: live vertebrates) Is the purpose limited? (E.g. for drug research, other scientific and educational purposes onl y, but not for cosmetics) Is the number regulated? (E.g. the „lowest possible”) Do you need any authorisation/notification to conduct animal experiments, or it is completely free?

11 A regulated quality assurance system, required for e.g. experimental toxicology in many developed countries : Good Laboratory Practice GLP

12 GLP What is GLP: a quality assurance system (to be delt with in the next semester) When should GLP be applied: for all non- clinical health and environmental safety studies (including toxicology in drug research) Health and environmental safety studies: when any new substance is innovated, its further safe handling several data are needed, e.g. melting point, flashing point, toxicity, etc. !

13 T hus, GLP: it is a quality assurance system dealing with the organisation and conduct of non-clinical health and environmental safety studies, including their planning, execution, control, do cumentation, archiving and the issue of their final report

14 We said „new substances”. What kind of new substances applies GLP ? drugs (both human and veterinary) phyto protective agents industrial/household „chemicals”

15 What „studies” are under G LP ? Physical and chemical Toxicit y (acut - chronic, reproduc t i vity, foetal, c arcinogeni city, lo cal toleranc e, toxi c okineti cs ) mutageni ci t y e kotoxi c ol o g y in aquatic and terrestrial organisms (continued)

16 What „studies” are under GLP? (continued) Degradation, bioaccumulation in water, soil and air Phyto protector residues Effects on micro-climas and natural ecosystems Analytical and clinical studies if connected to any listed above (clinical: veterinary!)

17 Animal experiments used for drug research… …more exactly: the non-clinical safety and efficacy studies (therapeutic benefit/risk) Are regulated by numerous guidelines („soft law”) – these will be mentioned in the part dealing with registration/authorisation!

18 Next topic: Regulation of human clinical trials §

Recognise: In the non-clinical part we used the terms „study” or „test” or „experiment” on animals In the human clinical part the similar activity is called „trial”! This is not a play with the words! The language of the regulation would like to underline that, when a drug is used first in humans, there are many safeguard measures and we are almost sure the result will be positive or at least does not harm the subjects! 19

Exam topic 20

Regulation of drug research Direct and indirect regulation (examples, please) The role of the „soft law” Regulation of animal experiments What is GLP? When should it be applied? (Definition, types of studies and substances to be studied) 21